An overview of ebola its history and the ebola vaccine

Many of the biggest drug companies are based in the same nations that provide the greatest support for research and development. Three different bat types are found to carry this virus without being affected that suggested them as a primary natural reservoir for Ebola viruses Cleavage produced three cleavage fragments, with masses of 23, 19, and 4 kDa Recovery may start 7 to 14 days after the first symptom Those who survive have many ongoing problems such as liver inflammation, muscular and joint pain, decreased hearing, weight loss and weakness.

Airborne mode of transmission between primates including humans is not observed yet either in natural conditions or in laboratories. Malaria, a febrile illness caused by parasites and spread by mosquito bites, is a vivid example. If these vaccines work for Ebola Zaire, it is very likely that the same principles can be applied to the other strains.

To facilitate rapid testing, CDC provided staff, training, and support to qualify 56 state and local public health laboratories to perform Ebola reverse transcription polymerase chain reaction RT-PCR testing for Ebola.

The Ebola Virus: An Overview

So why is a vaccine just now reaching the public in Africa? The outbreak spurred intense efforts on the part of health organizations, resulting in an experimental drug called ZMapp.

Human-to-human transmission of EBOV occurs through direct contact with the blood or body fluids e. Patients should be isolated, and strict barrier nursing techniques should be used, including wearing masks, gloves and gowns. From December to Septembera total of deaths were reported out of confirmed and probable cases of Ebola virus from five countries of West Africa i e, Guinea, Nigeria, Senegal, Liberia, and Sierra Leone Cases were first reported from forested areas in south-eastern Guinea.

Archives of Neuroscience

A safe VSV vaccine for animals has been developed for animal use but it is not currently marketed in the United States. Other infection control measures include proper use, disinfection, and disposal of instruments and equipment used in caring for patients.

Top Conclusion The Ebola epidemic of — took a profound toll on the lives of men, women, and children of Guinea, Liberia, and Sierra Leone who were affected by a disease that had never been seen in their part of the world.

This is the first time the disease has been detected in West Africa. They include fever, headache, chills, muscle and joint aches, and fatigue. Twice, Russian researchers have been infected while working with the virus in laboratories. Nigeria and Senegal had small outbreaks related to importations from neighboring countries, but public health authorities there were able to contain spread of the disease.

That is why it is very difficult to develop vaccine against Ebola virus. WHO does not recommend that any travel or trade restrictions be applied with respect to this event.

List of Ebola outbreaks

Isolation facilities and a mobile laboratory have been established; infection prevention and control and clinical management guidance is being provided; and awareness and education campaigns, social mobilization, and risk communications activities are taking place throughout the affected areas.

Infection and transmission In Africa, fruit bats are believed to be the natural hosts of Ebola virus. In total, by the time the epidemic was over in March11, confirmed, probable, and suspected deaths occurred. A small number of suspected cases and deaths has also been reported from neighbouring countries with all of them having crossed from Guinea.

Meanwhile, testing the vaccine had been ethically fraught.

Ebola virus disease: background and summary

Vaccine development began in the late s: The overall shape of virions varies considerably ranging from simple cylinders to branches, loops and reverse direction.Ebola virus disease: background and summary Disease Outbreak News 3 April - WHO is supporting the national authorities in the response to an outbreak of Ebola virus disease (EVD; formerly known as Ebola haemorrhagic fever).

Nature and History of Ebola Virus: An Overview Nature and History of Ebola Virus: An Overview, Arch Neurosci. ;3(3):e Despite the known severity of Ebola outbreaks, no effective vaccine or therapeutic drug is developed so far because of the RNA coded nature of this virus, but many candidate vaccines are going on trial basis.

epidemiological history of EHF can make the di erential diagnosis Nooshin Bagherani () An Overview on Ebola. Olopade CO () Drug and vaccine access in the ebola epidemic: advising. Nature and History of Ebola Virus: An Overview Muhammad Umair Majid, 1 Muhammad Sufyan T ahir, 1 Qurban Ali, 1,* Abdul Qayyum Rao, 1 Bushra Rashid, 1 Arfan Ali, 2 Idrees Ahmad Nasir, 1 and T.

The Ebola Virus: An Overview The West African Ebola outbreak was the largest Ebola outbreak in recorded history, with 21, cases in 9 countries resulting in a. An effective Ebola vaccine, despite the stop-and-go nature of its development, is now helping control the outbreak in the Democratic Republic of the Congo.

Under World Health Organization and national emergency-use approvals, public health and other aid workers are conducting a ring vaccination campaign, tracing back infected patients.

An overview of ebola its history and the ebola vaccine
Rated 0/5 based on 34 review